• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS, INC CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS, INC CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Model Number NOT APPLICABLE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hypersensitivity/Allergic reaction (1907); Itching Sensation (1943); Swelling (2091)
Event Date 06/15/2017
Event Type  Injury  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the medical intervention of the taligyl medication that was given to the patient.Since this event is associated with the treatment, this mdr will be against the instrument.From the device perspective, there was no known device malfunction and no instrument issue was alleged by the customer.No service was requested by the customer for this adverse event.No product was returned therefore, a device service history review was performed.The instrument has been located at the customer's site since 04/30/2013.As part of the review, it was determined that the instrument's last service was on 07/28/2016.During this service the system checkout procedure was successfully completed indicating that the instrument had passed all tests, met all specifications, and was operational.Trends were reviewed for complaint categories, allergic reaction, swelling, and other adverse event: itching throat.No trends were detected for these complaint categories.The assessment is based on information available at the time of the investigation.No product was returned for investigation; therefore, it could not be determined if the product met specification based solely on the information provided by the customer.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.Adverse event terms: swelling, itching, and hypersensitivity.(b)(4).Device not returned to manufacturer.
 
Event Description
The customer called to report a patient who exhibited the signs of an allergic reaction during a treatment procedure.The customer stated that the patient was being treated for severe mucous membrane pemphigoid.The customer reported that the patient to date had received a total of 10 treatments in a schedule of two consecutive treatment days occurring every other week.The customer stated that there had been no issues regarding the patient during those past treatments.The customer reported that during this treatment, the patient's 11th treatment, the patient experienced a mild reaction of swollen lips and an itching throat.The customer stated that the patient's symptoms occurred during the photoactivation phase of the treatment, prior to the reinfusion of any treated cells.The customer reported that the patient's symptoms were successfully treated with taligyl.The customer stated that the treatment was successfully completed and the treated cells were returned to the patient.The customer reported that the referring dermatologist informed them that a new medication, valaciclovir, was administered to the patient four days prior to this treatment cycle.The customer stated that this medication was administered to the patient in order to protect the patient from a chickenpox outbreak within the patient's family.The customer reported that they used their own solution of methoxsalen (20 mg/ml) for all their treatment procedures.No product was returned for investigation.
 
Manufacturer Narrative
Correction: the name of the medication that was administered to the patient when the patient's symptoms first occurred was miss- spelled in the initial medwatch for this case.The name of the medication is t.Tavegyl and not taligyl as initially reported.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS, INC
hampton NJ
Manufacturer (Section G)
THERAKOS, INC.
10 north high street
suite 300
west chester PA 19380
Manufacturer Contact
megan vernak
po box 9001
53 frontage road
hampton, NJ 08827
MDR Report Key6683558
MDR Text Key78902449
Report Number2523595-2017-00129
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeSW
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/01/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/01/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Nurse
Device Model NumberNOT APPLICABLE
Device Catalogue NumberCELLEX
Device Lot NumberNOT APPLICABLE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received07/07/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/21/2013
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age46 YR
-
-